Europe — EMA
Combivir (Zidovudine, Lamivudine)
Combivir is a combination medication containing Zidovudine and Lamivudine, used in the management of HIV infection. This oral medication is designed to support
Request sourcing
What is Zidovudine, Lamivudine?
Combivir is a combination medication containing Zidovudine and Lamivudine, used in the management of HIV infection. This oral medication is designed to support antiviral therapy, helping to control the virus in the body.
What is Zidovudine, Lamivudine used for?
Combivir is primarily used as part of antiretroviral therapy (ART) for individuals infected with HIV. The medication works by reducing the amount of HIV in the body, which can help improve immune function and reduce the risk of HIV-related complications. It is often prescribed in combination with other HIV medications to achieve optimal results.
What are the side effects of Zidovudine, Lamivudine?
Common effects of Combivir may include fatigue, headache, nausea, and diarrhea. Some individuals may also experience changes in body fat distribution. These effects can vary in intensity and duration, and not everyone will experience them.
What precautions apply to Zidovudine, Lamivudine?
Combivir should be used under the guidance of a healthcare professional. It is important to follow the prescribed dosage and schedule. Regular monitoring of blood cell counts and liver function may be necessary. Pregnant women or those planning to become pregnant should discuss the use of Combivir with their healthcare provider.
What does Zidovudine, Lamivudine interact with?
Combivir may interact with other medications, including certain antiviral drugs, antibiotics, and medications that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using Combivir.



